Shadach Eran, Feldon Joram, Weiner Ina
Department of Psychology, Tel-Aviv University, Ramat-Aviv, Tel-Aviv 69978, Israel.
Int J Neuropsychopharmacol. 1999 Dec;2(4):283-291. doi: 10.1017/S1461145799001583.
Latent inhibition (LI) refers to retarded conditioning to a stimulus as a consequence of its non-reinforced pre- exposure. LI is impaired in some subsets of schizophrenic patients and in rats treated with amphetamine. Antipsychotic drugs (APDs) potentiate LI under conditions that are insufficient to produce LI in control animals, namely, low number of pre-exposures or high number of conditioning trials. The present experiments tested the proposition that LI potentiation under both conditions stems from the action of APDs in the conditioning stage. Experiments 1-3 used 10 pre-exposures and 2 conditioning trials, and tested the effects of 2.5, 5, and 10 mg/kg clozapine, respectively. Experiments 4-6 used 40 pre-exposures and 5 conditioning trials, with clozapine doses as above. Clozapine was administered in either the pre-exposure, the conditioning stage, or in both. In all the experiments, vehicle controls did not show LI. Overall, clozapine administration in conditioning, irrespective of drug condition in pre-exposure, produced LI. The implications of these results for the mechanism of action of antipsychotic drugs are discussed.
潜伏抑制(LI)是指由于刺激在未强化的情况下预先暴露而导致对该刺激的条件反射延迟。在某些精神分裂症患者亚组以及用苯丙胺治疗的大鼠中,潜伏抑制受损。抗精神病药物(APD)在不足以在对照动物中产生潜伏抑制的条件下,即低预暴露次数或高条件反射试验次数时,会增强潜伏抑制。本实验检验了这样一个命题,即在这两种条件下潜伏抑制的增强都源于抗精神病药物在条件反射阶段的作用。实验1 - 3采用10次预暴露和2次条件反射试验,分别测试了2.5、5和10 mg/kg氯氮平的效果。实验4 - 6采用40次预暴露和5次条件反射试验,氯氮平剂量同上。氯氮平在预暴露阶段、条件反射阶段或两个阶段都给药。在所有实验中,溶剂对照组均未表现出潜伏抑制。总体而言,无论预暴露阶段的药物情况如何,在条件反射阶段给予氯氮平都会产生潜伏抑制。讨论了这些结果对抗精神病药物作用机制的意义。